1)Insulin/therapeutic use胰岛素/治疗应用 2)use of exogenous insulin使用胰岛素治疗 1.Objective To investigate the relationship between the use of exogenous insulin and DR by 1∶1 matched Case control study.目的 用 1∶1配比的病例对照研究探讨使用胰岛素治疗与糖尿病视网膜病变 (DR)的关系。 英文短句/例...
A. Chantelau, "Differences in bioactivity between human insulin and insulin analogues approved for therapeutic use-compilation of reports from the past 20 years," Diabetology and Metabolic Syndrome, vol. 3, no. 1, article 13, 2011.Werner H, Chantelau EA. Differences in bioactivity between human...
p pIn order to provide comprehensive information on the differences in bioactivity between human insulin and insulin analogues, published itin vitro /itcomparisons of human insulin and the rapid acting analogues insulin lispro (Humalogsup/sup), insulin aspart ( NovoRapidsup/sup), insulin glulisine (...
Ssc.15986.1.S1_at Insulin receptor 29.28 −16.85 −17.70 −19.01 INSR insulin, insulin aspart, insulin glulisine, insulin lispro, insulin glargine Ssc.873.1.S1_at Cell division control protein 2 27.38 −2.37 −4.66 −7.76 CDC2 flavopiridol Ssc.29928.1.A1_at Histone deacetylase 11 (HD11...
Humalog Mix 50/50 (50% insulin lispro protamine suspension, 50% insulin lispro solution), Eli Lilly >22 hours Typically given pre-breakfast and pre-supper.3 Give within 15 min before the meal. $284.70/10 mL vial $530.40/5 of 3 mL KwikPen ($106.08 each) Vial: 28 days Pen: 10 ...
recombinant Insulin Lispro (Eli Lily) diabetes (type I and II) Insulin recombinant Novolin R ™ (Novo Hypoglycemic Agents For treatment of 156308 Nordisk) diabetes (type I and II) Insulin, porcine Iletin II ™ Hypoglycemic Agents For the treatment of 156308 diabetes (type I and II) ...
aided in resolving PRP’s hair growth limitations. On the other hand, it has been demonstrated that the use of bioactive collagen peptides helps to promote nail development. Further advances in the fields of protein therapeutics may open up a plethora of new treatment options for cutaneous ...
Since the nucleation-dependent aggregation process can be either homogeneous or heterogeneous, we account for both types of aggregation in our work.;We investigate homogeneous nucleated aggregation using two insulin analogues, biosynthetic human insulin and lispro insulin, as model proteins. We show that...